New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant systemic sclerosis
New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high ...
Jul 9, 2026
0
4









